Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division
(Adnkronos) – BOSTON, July 12, 2023 /PRNewswire/ — Medicilon, a leading one-stop pharmaceutical preclinical R&D service platform CRO, recently appointed Dr. Liu Jian as the President of Drug Discovery Division. Medicilon recognizes
